Abstract 5728
Background
The current literature on stage IV colorectal cancer (CRC) indicates a survival advantage for left-sided CRC. Still, the biological basis remains unclear. We assessed the interaction of cancer location with microsatellite instability (MSI) and KRAS mutation to elaborate how key molecular features modify the effect of cancer location on overall survival.
Methods
The 2010-2015 United States National Cancer Database was searched for stage IV colorectal adenocarcinomas. Overall survival (OS) was assessed via Cox models, implementing 2/3-way interaction terms.
Results
A total of 73,685 patients were included, of which n = 11,720/n=25,433 had data on microsatellite and KRAS status. Left-sided CRC was an independent predictor of improved OS (vs. right: HR = 0.75, p < 0.001). Rectal cancer had highest OS (2/5-year OS: 43%/10%) compared to cancers of the rectosigmoid junction (HR = 1.07), sigmoid (HR = 1.12), descending colon (HR = 1.19), transverse colon (HR = 1.41), ascending colon (HR = 1.45) or cecum/appendix (HR = 1.45, p < 0.001 respectively). Patients with stable microsatellites (MSS) had improved OS versus MSI (HR = 0.93, p = 0.027); KRAS wildtype showed superior OS over KRAS mutation (HR = 0.88, p < 0.001). CRC location interacted with microsatellite status and KRAS mutation: the prognostic impact of MSS was more pronounced in rectal cancers versus other locations (interaction p < 0.001); the prognostic impact of KRAS wildtype was larger in rectal cancers (interaction p < 0.001). In a 3-way interaction model, the largest prognostic impact of MSS and KRAS wildtype was noted for rectal cancer (interaction term p < 0.05). The table summarizes 2/4-year OS rates.Table: 529P
Adjusted 2-year and 4-year OS rates by cancer location and mutational status
| Location / mutational status | Two year OS | Four year OS |
|---|---|---|
| rectal CRC, MSS, KRAS wildtype | 68% | 38% |
| rectal CRC, MSS, KRAS mutation | 56% | 29% |
| rectal CRC, MSI, KRAS wildtype | 66% | 39% |
| rectal CRC, MSI, KRAS mutation | 43% | 18% |
| other CRC, MSS, KRAS wildtype | 60% | 31% |
| other CRC, MSS, KRAS mutation | 52% | 24% |
| other CRC, MSI, KRAS wildtype | 47% | 25% |
| other CRC, MSI, KRAS mutation | 48% | 20% |
Conclusions
Survival for stage IV CRC shows marked variation depending on location, MSI and KRAS mutation. The prognostic effects of molecular features varies by CRC location, demonstrating largest impact in rectal cancers.
Clinical trial identification
NA
Legal entity responsible for the study
Hyun S. Kim, MD.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1978 - FAM115c that upregulates proliferation and invasion under hypoxia could be a predictive biomarker for pancreatic cancer.
Presenter: Kiyoshi Saeki
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3682 - Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)
Presenter: Annikka Weissferdt
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3319 - Tumor-infiltrating CD3+ lymphocytes and ICOS+ T-cells predict a favorable survival in resected esophageal squamous cell carcinoma
Presenter: Min Hee Hong
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5130 - Chemokine receptor CXCR7 expression, function and clinical implications in head and neck squamous cell carcinoma
Presenter: Myung-Won Lee
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4483 - Assessment of PD-1/PD-L1 colocalization in hepatocellular carcinoma (HCC) using bright-field double labeling and quantitative digital image analysis
Presenter: Thomas Mrowiec
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1175 - Pulmonary tumor thrombotic microangiopathy (PTTM): 24 case series and its criteria for pathological diagnosis.
Presenter: Naoko Sato
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1359 - Autofluorescence: a new marker for identifying cancer stem cells (CSCs) in primary tumors
Presenter: Miriam López Gómez
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2651 - NACC1 as a target of microRNA-331-3p regulates cell proliferation in urothelial carcinoma cells
Presenter: Kohei Morita
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2233 - Somatic-stem transition of tumor cells is a key link in the metastasis
Presenter: Nicolai Litviakov
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2601 - Profile of individuals who never undergo colorectal cancer screening
Presenter: Jérôme Viguier
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract